You are here » Home » Companies » Company Overview » Vivo Bio Tech Ltd

Vivo Bio Tech Ltd.

BSE: 511509 Sector: Health care
NSE: N.A. ISIN Code: INE380K01017
BSE LIVE 14:47 | 15 Dec 42.45 2.00
(4.94%)
OPEN

42.40

HIGH

42.45

LOW

42.00

NSE 05:30 | 01 Jan Stock Is Not Traded.
OPEN 42.40
PREVIOUS CLOSE 40.45
VOLUME 2660
52-Week high 100.00
52-Week low 40.00
P/E 15.96
Mkt Cap.(Rs cr) 40
Buy Price 42.45
Buy Qty 2635.00
Sell Price 0.00
Sell Qty 0.00
OPEN 42.40
CLOSE 40.45
VOLUME 2660
52-Week high 100.00
52-Week low 40.00
P/E 15.96
Mkt Cap.(Rs cr) 40
Buy Price 42.45
Buy Qty 2635.00
Sell Price 0.00
Sell Qty 0.00

Vivo Bio Tech Ltd. (VIVOBIOTECH) - Company History

Vivo Bio Tech is a full service CRO offering drug development & discovery services to pharmaceutical & biotech companies world-wide in accordance with OECD AAALAC & IND guidelines. The company offers services in the areas of In vitro In vivo toxicity studies pharmacological investigations pharmacokinetics & toxicokinetic studies etc. Our experienced & talented scientists offer advice on defining drug development paths tailored to specific molecules. Tailored and dedicated to our clients we distinguish your development plan is as superlative as the products you bring to our testing facilities.The Biologic Research Services group at Vivo Bio Tech offers a complete line of protein services including gene synthesis cloning expression and purification of recombinant proteins and monoclonal antibodies. Our scientists will team up with you to develop solution for the most difficult to deal products including purification of untagged & poorly expressed proteins.In-vitro Services offers solutions for pharmacologic toxicological & bioanalytical investigations in drug discovery & development. Critical investigations like bacterial reverse mutation assays chromosomal aberration and micronucleus are specialty services by our scientists.The In-vivo Services group at Vivo Bio Tech provides both non-regulatory and regulatory IND enabling preclinical development services. We are capable of screening & evaluating molecules for various pharmacological & therapeutic properties. Specifically for oncology our scientists can provide design & development of xenograft models for evaluation of anti-cancer agents. Further our scientists can customize in-vivo DMPK studies to help profile your drug candidate in both rodent and non-rodent animal models.Vivo Bio has partnered with Taconic for sourcing foundation and expansion colonies of the animal models and have started in-house breeding of Specific Pathogen Free rodents.